FRISCO, Texas, Aug. 20, 2021 /PRNewswire/ — Argon Medical Devices, Inc., a leading manufacturer of medical devices for interventional procedures, announced the commercial launch of SKATER™ Mini-Loop Drainage Catheters in the United States and the European Union. 

The SKATER™ Mini-Loop is a drainage catheter placed through the skin using imaging guidance as a minimally invasive way to remove or drain an unwanted fluid collection. The SKATER™ Mini-Loop Drainage Catheter is an expansion of Argon’s SKATER™ All-Purpose and Nephrostomy drainage portfolio, and it uses a 40% smaller loop to help secure the catheter and drain fluid from smaller cavities.

“Argon’s Mission is to deliver innovative, best-in-class medical devices to improve the customer experience and the lives of their patients. We are excited to complete our SKATER™ portfolio of drainage solutions and celebrate this next launch in our Year of Innovation,” said George A. Leondis, President and CEO of Argon Medical Devices.

“The SKATER™ Mini-Loop Drainage Catheter is easily inserted and forms a tight loop formation to prevent drainage occlusion. Unlike other drainage catheters in the class, SKATER™ Mini-Loop is compatible with alcohol and has durability to resist kinking, which is important to me.” said Dr. Sujoy Menon, an Interventional Radiologist at Newark Beth Israel Medical Center. Dr. Menon and Dr. Sayed Ali, a resident of the Rutgers Medical School, were the first physicians in the United States to use the SKATER™ Mini-Loop Drainage Catheter.

Argon Medical Devices introduced several new devices in the biopsy, drainage, and vascular therapy segments in 2020, despite the global pandemic. The company refers to 2021 as its Year of Innovation because it plans to launch even more innovative new products throughout the year to help facilitate interventional vascular and oncology procedures.

FRISCO, Texas, April 6, 2021 /PRNewswire/ — Argon Medical Devices, Inc., a leading manufacturer of medical devices focused exclusively on interventional procedures, announced the U.S. commercial launch of Halo^™ Single-Loop Snare Kits. 

The Halo Single-Loop Snare Kit is designed to provide both accuracy and reliability when retrieving and manipulating foreign objects from the cardiovascular system or hollow viscus. 

“We are excited to expand our portfolio of solutions with the addition of the Halo Single-Loop Snare Kits to our vascular snare product line,” said George A. Leondis, President and CEO of Argon Medical Devices. “We are committed to providing our customers a broad line of best-in-class medical devices to provide high-quality care for their patients, and this addition allows us to continue to fulfill that commitment.”

The Halo Single-Loop Snare Kit is designed to improve procedural efficiency through the addition of a reusable, peel-away insertion tool for easy assembly and 15° angulation on the snare catheter for directional control. 

“The 15° angulation on the snare catheter is beneficial for positioning when retrieving a foreign body that is positioned against the wall of an artery or vein”, said Dr. Daniel George who was the first physician in the United States to use the Halo Single-Loop Snare. Dr. George is the lead Interventional Radiologist at St. Elizabeth’s Hospital in Beaumont, TX.

Argon Medical Devices began 2020 with the launch of the Single-Loop and Triple-Loop Retrieval Kits for use when removing a patient’s implanted vena cava filter. Subsequently, Argon Medical Devices introduced several new devices in the biopsy, drainage, and vascular therapy segments in 2020, despite the global pandemic. The company refers to 2021 as the Year of Innovation because it plans to launch even more innovative new products this year to help facilitate interventional vascular and oncology procedures.

FRISCO, Texas, Jan. 22, 2020 /PRNewswire/ — Argon Medical Devices, Inc. announced today the commercial launch of Single-Loop and Triple-Loop Retrieval Kits for sale in the U.S. The Single-Loop and Triple-Loop Retrieval Kits are intended for percutaneous removal of retrievable inferior vena cava (IVC) filters that are no longer medically required, via a jugular approach.

“We are excited to improve the IVC filter retrieval options available to our customers with the introduction of these new products,” said George A. Leondis, President and CEO of Argon Medical Devices, Inc. “Our Single-Loop and Triple-Loop Retrieval Kits are the only two kits cleared by the FDA for removing any retrievable IVC filter from a jugular approach. These new products further demonstrate our dedication to our mission to improve the lives of patients and caregivers through the innovation of best-in-class medical devices.” 

Argon Medical’s Single-Loop and Triple-Loop Retrieval Kits were designed with the rigor of the IVC filter retrieval in mind and offer the following key features:

• A coil-reinforced outer sheath with the strength needed to detach filter legs from the IVC wall 
• Radiopaque bands on the distal end of the inner sheath, outer sheath and the snare catheter for enhanced visualization 
• A fifteen-degree curve at the distal tip of the snare catheter for directional control

“IVC filters are a safe and effective treatment for the prevention of pulmonary embolism (PE), however they should be removed when the need for the filter subsides,” said Dr. David Trost of Weill Cornell Medical Center in New York. “I like that Argon’s new retrieval kits can be used on all retrievable IVC filters, regardless of brand, from the jugular vein, providing unique versatility.”

FRISCO, Texas, July 9, 2019 /PRNewswire/ — Argon Medical Devices, Inc., a leading global manufacturer of specialty medical devices used in interventional procedures, announced today that it has entered into a definitive license agreement with Hatch Medical, L.L.C. (“Hatch Medical”) for exclusive global rights to market and distribute the Scorpion™ TIPS Access Systems. 

“We are excited about the addition of the Scorpion TIPS Access Systems to our product portfolio. This technology is positioned to become the leader in this disease segment and we are confident it will prove to be the preferred device of its kind,” said George A. Leondis, President and CEO of Argon Medical Devices, Inc. “This partnership provides a compelling strategic opportunity for Argon, allowing us to provide our customers with another best in class product in the Interventional arena.”

“We are pleased to have secured such a strong partner for this procedure-changing product line.  Argon Medical is recognized as a world class manufacturer with tremendous depth and global distribution resources,” commented Paul Gianneschi, Managing Principal and Founder of Hatch Medical.

A transjugular intrahepatic portosystemic shunt (TIPS) is a tract created within the liver using x-ray guidance to connect two veins within the liver. Patients who are in need of  TIPS procedures commonly suffer from portal hypertension, often caused by hepatitis c and alcohol related cirrhosis.  

“The addition of the Scorpion TIPS Access Systems into our product portfolio further strengthens Argon’s ongoing commitment to the diagnosis and the treatment of patients with liver disease,” said Christian A. Chilcott, Senior Vice President of Global Marketing for Argon. “It’s estimated that approximately 4.5 million people are diagnosed with liver disease each year, with over 40,000 cases being fatal. The Scorpion TIPS Access Systems are the first liver access sets to provide physicians the ability to reliably control the direction and angle of the needle tip, reducing the number of unsuccessful procedures.”

FRISCO, Texas, May 30, 2019 /PRNewswire/ — Argon Medical Devices, Inc., a global manufacturer of specialty medical devices used in interventional procedures, announced today that it has completed the acquisition of Mana-Tech, Ltd., its exclusive distributor for the United Kingdom and Ireland.

For more information on Argon Medical’s products & services visit www.argonmedical.com.

“The acquisition of Mana-Tech, Ltd. represents a compelling growth opportunity to expand our commercial reach in the UK, Ireland and throughout Europe,” George Leondis, President and Chief Executive Officer of Argon Medical Devices, commented. “We are excited to have this very talented group join Argon and to work even more closely with them to continue their successful growth trajectory.”

The entire Mana-Tech team, including its management, sales, customer service and distribution groups, will join Argon as part of the acquisition.